The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH are collaborating on a human trial…

Bristol-Myers Squibb's Opdivo is in more vaccine combo studies than its PD-1/PD-L1 rivals, according to a new report.

Dendreon unveiled new data at ASCO showing Provenge generates a killer T-cell response that correlates with overall survival.

A Sanofi executive has explained the rationale behind the company’s Zika vaccine development plan and is issuing a defense against claims his company is out to…

Sanofi got more than it bargained for when it teamed up with the U.S. Army to develop a Zika shot.

Malaria parasites can shuffle genes to create different strains, a phenomenon that could put the efficacy of Glaxo’s vaccine Mosquirix, among others, into…

European biotech Vaximm has partnered with much bigger drug companies Merck KGaA and Pfizer to test a cancer vaccine/checkpoint inhibitor combo.

The highly valued yet mysterious Moderna provided a peek at its first human data, reporting positive interim results from a phase 1 trial testing its mRNA-…

R&D